Microbiology & Infectious Diseases

A recent perspective highlights challenges in translating human microbiome research into consistent clinical benefits and precision interventions.

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated urinary tract infection.

Children facing economic instability and poor social support in the USA have higher odds of long COVID, highlighting the role of social determinants in child health.

Delayed routine infant vaccinations strongly predict missed MMR doses by age 2, raising concern as post-pandemic declines coincide with rising measles cases in the USA.

Adult bacterial meningitis continues to carry high mortality and neurological complications, especially from Listeria, Streptococcus pyogenes, and pneumococcus.

New evidence shows human rhinovirus can directly infect the lower lungs and cause pneumonia in adults, challenging its reputation as a mild cold virus.

Ants produce diverse, targeted antimicrobial compounds that inhibit drug-resistant pathogens, including Candida auris, offering insights for new antibiotics.

A multi-omics study identifies causal genes and biological subtypes of Long COVID, revealing new therapeutic targets for personalised care.